Breast Cancer Research | Articles which cite: Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.

printer friendly

to [Help]

BioMed Central articles that cite the above article:

Review

Breast cancer stem cells: tools and models one can rely on
Charafe-Jauffret E, Ginestier C, Birnbaum D
BMC Cancer 2009, 9:202 (25 June 2009)
[Abstract] [Provisional PDF] [PubMed] [Related articles]

Viewpoint

Number crunching in the cancer stem cell market
Alison MR, Islam S, Lim SML
Breast Cancer Research 2009, 11:302 (24 April 2009)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

Review

Centrosome-associated regulators of the G₂/M checkpoint as targets for cancer therapy
Wang Y, Ji P, Liu J, Broaddus RR, Xue F, Zhang W
Molecular Cancer 2009, 8:8 (13 February 2009)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

Viewpoint

Regulation of cancer stem cells by p53
Jerry DJ, Tao L, Yan H
Breast Cancer Research 2008, 10:304 (29 August 2008)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

Review

Breast cancer stem cells: implications for therapy of breast cancer
Morrison BJ, Schmidt CW, Lakhani SR, Reynolds BA, Lopez JA
Breast Cancer Research 2008, 10:210 (22 July 2008)
[Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

Editorial

Research

Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1
Wright MH, Robles AI, Herschkowitz JI, Hollingshead MG, Anver MR, Perou CM, Varticovski L
Molecular Cancer 2008, 7:29 (7 April 2008)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 2 articles in PubMed Central

You can also check ISI Web of Science for additional citations (subscription required)

printer friendly

to [Help]